Risk Partners Life Sciences Roundtable 2025, thank you very much! 

Contact us

What are the capital requirements for a capital management company?

Together with experts Johannes Kiefer (Director of Risk & Compliance at Landsiedel & Partner) and Henry Franz (Managing Director of Layline.tax), we were able to compile our complementary expertise on capital requirements, ranging from registered KVGs to fully licensed KVGs. In this issue of VC Magazine, we share how E&O insurance, among other things, can provide added value. In addition to our article available below, please also see the link to the online edition of Venture Capital Magazine. 

Enjoy reading. 

PDF Title
Download

Also read our other blog posts
Life Sciences

Cyber Risks: Case Study Evotec

Last year, more than 10 percent of German companies were affected by an IT security incident, with the proportion rising due to cyber attacks. Biotechnology is not excluded either. It is possible to learn from the Evotec case. It is about successful cyber attacks or other incidents that are important for security, such as acts of sabotage or hardware theft. According to a representative Ipsos survey conducted on behalf of the TÜV association among 501 companies with more than ten employees. According to the TÜV

Read more "
October 22, 2023
IPO

New: Risk Partners POSI Insurance for MiCAR White Paper

MiCAR Compliance? We Cover the Risk! The MiCAR Regulation (EU 2023/1114) exposes crypto-asset service providers and whitepaper authors to significant liability risks. Incomplete, inaccurate, or misleading information in white papers can have significant consequences for Crypto-Asset Service Providers (CASP) and authors—ranging from regulatory sanctions to civil claims. Our solution: Risk Partners Tech POSI MiCAR Whitepaper Protect 2025 The creation and publication of white papers under MiCAR entails complex liability pitfalls: In addition to civil claims (e.g., under the German Civil Code) and criminal risks, there is a threat of

Read more "
March 21, 2026
Management

Capital requirements for (fully regulated) AIFMs

What are the capital requirements for an asset management company? Together with experts Johannes Kiefer (Director of Risk & Compliance at Landsiedel & Partner) and Henry Franz (Managing Director of Layline.tax), we were able to compile our combined expertise on capital requirements, ranging from registered asset management companies to fully licensed ones. In this issue of VC Magazine, we share how E&O insurance, among other things, can provide added value. In addition to our article available below, please also check out the link to the online edition of Venture Capital Magazine. Enjoy!

Read more "
March 30, 2026
Being Public

Global Integrity and Compliance Forum 2024 

𝗚𝗹𝗼𝗯𝗮𝗹 𝗜𝗻𝘁𝗲𝗴𝗿𝗶𝘁𝘆 𝗮𝗻𝗱 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗙𝗼𝗿𝘂𝗺 𝟮𝟬𝟮𝟮𝟰 "D&O and Co. - Plan B to cover personal liability!" Last Friday, Florian had the honor of taking part in the Global Integrity and Compliance Forum at the Ludwig-Maximilians-Universität in Munich. Under the motto "The RULE of LAW in the Era of Integrity & Compliance", international legal experts, company managers, in-house councils and compliance officers from all over the world gathered to discuss the future of good corporate governance in 2024. Key discussions and insights One of the

Read more "
June 14, 2024
Cyber Security

"Digital Operational Resilience Act" (DORA regulation) from the perspective of venture capital and private equity funds

DORA regulation applies from January 2025. Significance for our private equity and venture capital clients The somewhat unwieldy name "Digital Operational Resilience Act" (DORA for short) has a very serious background and is fundamentally to be welcomed. After all, when we evaluate our claims in the context of cybercrime, PE and VC funds and their KVGs are those with the highest frequency of claims. It can be safely assumed that they are a "worthwhile target group" for cyber criminals based abroad.

Read more "
December 27, 2024
Life Sciences

Finance Day 2023

Growth capital for biotechnology: Yesterday, today, tomorrow! A few days ago, Jutta Zaglauer and Florian Eckstein from our team attended the Finance Day 2023 on the occasion of the 25th anniversary of biotechnology at the IZB - Innovation and Startup Center for Biotechnology. The event offered an exciting exchange and insights into current financing and capital market issues of biotechnology companies. As an experienced specialist insurance broker for the areas of life sciences, venture capital and IPOs, all three cornerstones of our "magic expertise triangle" were part of the exciting agenda. It was also interesting to discuss the importance of customized

Read more "
November 6, 2023